Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
37.23B | 35.59B | 37.10B | 35.56B | 33.49B | Gross Profit |
18.60B | 17.49B | 20.74B | 19.47B | 18.45B | EBIT |
18.07B | 17.01B | 18.62B | 17.42B | 16.55B | EBITDA |
22.42B | 21.12B | 22.93B | 22.50B | 20.66B | Net Income Common Stockholders |
16.32B | 15.46B | 17.08B | 16.01B | 15.12B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
37.31B | 27.78B | 33.13B | 22.80B | 28.60B | Total Assets |
538.27B | 510.80B | 507.66B | 495.62B | 484.57B | Total Debt |
230.40B | 205.40B | 202.90B | 206.90B | 196.52B | Net Debt |
193.09B | 177.62B | 169.77B | 184.10B | 167.92B | Total Liabilities |
263.35B | 237.05B | 234.05B | 237.97B | 228.17B | Stockholders Equity |
274.92B | 273.75B | 273.60B | 257.65B | 256.40B |
Cash Flow | Free Cash Flow | |||
8.88B | 6.58B | 15.13B | -1.10B | -12.23B | Operating Cash Flow |
39.99B | 22.35B | 29.47B | 30.64B | 20.37B | Investing Cash Flow |
-39.67B | -15.23B | -14.35B | -32.04B | -30.18B | Financing Cash Flow |
9.84B | -12.80B | -5.17B | -4.45B | 13.43B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | $362.97B | 22.24 | 5.84% | 4.36% | 44.54% | 5.60% | |
61 Neutral | $2.86B | 10.96 | 0.41% | 6.08% | 5.73% | -21.25% | |
€1.70B | 19.71 | 5.11% | 5.32% | ― | ― | ||
$2.18B | ― | 5.74% | 19561992.57% | ― | ― | ||
€1.83B | 16.91 | 7.72% | 5.95% | ― | ― | ||
70 Outperform | ¥292.52B | 25.74 | 3.90% | -3.25% | -2.56% | ||
¥326.16B | 28.07 | 18.39% | ― | ― |